Releases Geral
Cinema, Italian Golden Globe to documentary on Gianni Agnelli produced by Marco Durante
AGÊNCIA DE COMUNICAÇÃO Conteúdo de responsabilidade da empresa 2 de outubro de 2023
La Presse
ROME, July 07, 2023 (GLOBE NEWSWIRE) — “Gianni Agnelli, in arte l’Avvocato” has been awarded the 2023 Globo dOro, i.e. Italian Golden Globe, as Best Documentary. “This is the most important recognition we have received. We have been investing in television for four years: this is the first award for an important documentary. Important because I have a personal connection to it. I lived with the Avvocato, I knew him very well and I called him Giovanni unlike the others who called him Gianni or lAvvocato,” said the founder and President of LaPresse, Marco Durante, who produced the documentary. The film portrait of the Avvocato won the statuette on the evening that the Italian Foreign Press Association devotes every year to Italian cinema. Receiving the prize at Villa Massimo was the film director Emanuele Imbucci, sharing the stage with giants from the world of Italian and international cinema such as John Malkovich and Marco Bellocchio. “I am happy because this award is not for me but for LaPresse. There is not a day, month or year that we do not take a step forward. And this is not thanks to me but rather to the machine we have created,” Durante continued. “Who do I dedicate this award to? To Avvocato Agnelli. Without him I would not be who I am. If I had not met Donna Marella, I would not have learnt manners. If I had not met the Avvocato, I would not be the person I am now.”
For more information:
Press Office LaPresse – ufficio.stampa@lapresse.it
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e516bccf-6d3e-4be7-bfa7-56915f8d4817
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
A OESP nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da OESP e sao de inteira responsabilidade da GlobeNewswire
Leia também
-
Releases Geral Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative join forces to combat vision loss from diabetes
12 de novembro de 2024·More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adu
Saiba Mais -
Releases Geral Aprendizado e networking marcam encontro de empreendedores
24 de abril de 2024(DINO - 24 abr, 2024) - Cerca de 120 pessoas, entre empreendedores e integrantes de suas famílias, participaram, na primeira semana de abril, da 3ª ediçã
Saiba Mais -
Releases Geral Junshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC Patients
2 de janeiro de 2024Junshi Biosciences SHANGHAI, China, Jan. 02, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven
Saiba Mais